Italy mRNA Synthesis & Manufacturing Market (2024-2029)
The Italy mRNA Synthesis & Manufacturing Market was valued at $13.59 Million in 2024 and projected to reach to $16.63 Million by 2029, representing a compound annual growth rate of 4.1%. Italy's mRNA synthesis and manufacturing market is poised for steady growth through 2029, driven by increasing biopharmaceutical investments and healthcare sector modernization.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Italy mRNA Synthesis & Manufacturing Market Trends and Insights
- Italy's market reflects steady expansion driven by increasing investment in biopharmaceutical infrastructure and growing demand for mRNA-based therapeutics across the country.
- The Italian healthcare sector's commitment to advancing gene therapy and vaccine manufacturing capabilities continues to support market development through 2029. Italy's position within Europe's broader mRNA ecosystem positions the country as an emerging hub for synthesis and manufacturing activities.
- Italy's pharmaceutical industry is leveraging technological advancements and regulatory support to enhance production capacity and competitiveness.
- By 2029, Italy is expected to capture greater market share as domestic and international biopharmaceutical companies expand operations and establish manufacturing partnerships within the region..
Key Market Statistics
- CAGR (2024-2029) 4.1% CAGR
- Market Size, 2024 ~USD 13.59 Million
- Forecast, 2029 ~USD 16.63 Million
- Country Italy
Italy mRNA Synthesis & Manufacturing Market Overview
Market Valuation Growth :
Italy's mRNA synthesis and manufacturing market reached $13.59 million in 2024, with projections to expand to $16.63 million by 2029, demonstrating consistent market maturation and investment confidence in the sector.
Steady CAGR Performance :
The Italian market is growing at a 4.1% CAGR through 2029, slightly below the global average of 5.8%, reflecting a more conservative but stable expansion trajectory within Europe's healthcare landscape.
Biopharmaceutical Infrastructure Investment :
Italy is experiencing increased capital allocation toward biopharmaceutical manufacturing facilities and mRNA production capabilities, positioning the country as an emerging hub for advanced therapeutic development in Southern Europe.
Rising mRNA Therapeutic Demand :
Growing adoption of mRNA-based therapeutics across Italian healthcare institutions is driving demand for specialized synthesis and manufacturing services, supported by regulatory frameworks and healthcare sector modernization initiatives.
Italy mRNA Synthesis & Manufacturing Market Dynamics
- The country's strategic position within the European Union, combined with strengthening regulatory infrastructure, creates favorable conditions for mRNA technology adoption and manufacturing expansion.
- Italian pharmaceutical companies and research institutions are progressively integrating mRNA capabilities into their portfolios. The market outlook remains positive as Italy continues to develop specialized manufacturing infrastructure and attract international biopharmaceutical partnerships.
- Government support for life sciences innovation and EU funding initiatives are expected to accelerate market development.
- However, growth will remain measured compared to global benchmarks, reflecting Italy's emerging status in the mRNA sector relative to established biotech hubs..
Related Ecosystem
Advanced Genetic Sequencing
- Polymerase Chain Reaction (PCR)
- Reagents
- Assay Kits
- Bioinformatics
- Flow Cytometry
- Thermo Fisher Scientific Inc.
- Illumina, Inc.
- Agilent Technologies, Inc.
- Qiagen N.V.
- Danaher Corporation
Analytical And Scientific Instrumentation
- Environmental Testing
- Gas Chromatography
- Polymerase Chain Reaction (PCR)
- Automated Liquid Handling Systems
- Flow Cytometry
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Agilent Technologies, Inc.
- Shimadzu Corporation
- Merck KGaA
Pharmaceuticals
- Bioreactors
- Analytical Testing
- Bioanalytical Testing Services
- Cell Counters
- Data Management Services
- Thermo Fisher Scientific Inc.
- SANOFI
- Merck KGaA
- NOVARTIS
- Pfizer Inc.
Key Takeaways
- Italy's mRNA synthesis & manufacturing market is valued at $13.59 million in 2024 with projected growth to $16.63 million by 2029.
- Italy demonstrates a 4.1% CAGR, reflecting steady but moderate growth compared to global expansion rates in the mRNA sector.
- Italy's pharmaceutical infrastructure and regulatory environment support increasing investment in mRNA manufacturing capabilities.
- Italy is positioned as an emerging regional hub within Europe for mRNA synthesis and biopharmaceutical production expansion.
mRNA Synthesis & Manufacturing Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | MRNA SYNTHESIS & MODIFICATION SERVICES (Service) |
| Forecast Period | 2024-2029 |
| Growth Rate | CAGR of 5.8% from 2024 to 2029 |
| Largest Segment | CONSUMABLES (Product) |
| Market Size Base Year (Billions) | ~USD 2.23 (2024) |
| Revenue Forecast (Billions) | ~USD 2.96 (2029) |
| Segments Covered | Product, Type, Application, End User, Service, Consumables, Transcription Consumables, Purification Consumables, Analysis & Characterization Consumables |
Italy mRNA Synthesis & Manufacturing Market Report Segmentation
9 segment dimensions are covered across the global market.
By Product
- Consumables
- Instruments
By Type
- Analysis & Characterization Consumables
- Analysis Kits And Reagents
- Chromatography Filters & Membrane
- Mrna Profiling Kits
- Mrna Synthesis Kits
- Nucleotides
- Other Products
- Other Purification Consumables
- Other Transcription Consumables
- Plasmid Dna/Dna Templates
- Purification Consumables
- Purification Kits & Reagents
- Rna Polymerases
- Transcription Consumables
- Vectors
By Application
- Cell & Gene Therapies
- Other Applications
- Vaccines
By End User
- Academic & Research Institutions
- Cros & Cdmos
- Cros And Cdmos
- Pharmaceutical & Biotechnology Companies
- Small-Scale Cros & Cdmos
By Service
- Manufacturing & Scale-Up Services
- Mrna Analysis & Characterization Services
- Mrna Purification Services
- Mrna Synthesis & Modification Services
By Consumables
- Analysis & Characterization Consumables
- Purification Consumables
- Transcription Consumables
By Transcription Consumables
- Mrna Profiling Kits
- Mrna Synthesis Kits
- Nucleotides
- Other Transcription Consumables
- Plasmid Dna/Dna Templates
- Rna Polymerases
- Vectors
By Purification Consumables
- Chromatography Filters & Membranes
- Other Purification Consumables
- Purification Kits & Reagents
- Purification Kits And Reagents
By Analysis & Characterization Consumables
- Analysis Kits & Reagents
- Analysis Kits And Reagents
- Other Analysis & Characterization Consumables
ITALY: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022–2029
| Segment | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| ACADEMIC & RESEARCH INSTITUTIONS | 4.9 | 3.6 | 3.6 | 3.7 | 3.8 | 4 | 4.1 | 4.4 | 4.1 |
| CROS & CDMOS | 4.3 | 3.1 | 3.1 | 3.2 | 3.3 | 3.5 | 3.6 | 3.8 | 4.1 |
| PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES | 11.6 | 8.5 | 8.5 | 8.7 | 9.1 | 9.5 | 9.9 | 10.5 | 4.3 |
| TOTAL | 20.8 | 15.2 | 15.2 | 15.6 | 16.3 | 17 | 17.7 | 18.7 | 4.2 |
ITALY: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022–2029
| Segment | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| ACADEMIC & RESEARCH INSTITUTIONS | 2.6 | 2.2 | 2.2 | 2.3 | 2.5 | 2.6 | 2.8 | 3.1 | 6.4 |
| PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES | 7.5 | 6.5 | 6.5 | 6.8 | 7.2 | 7.7 | 8.3 | 9 | 6.9 |
| SMALL-SCALE CROS & CDMOS | 1 | 0.8 | 0.8 | 0.8 | 0.9 | 0.9 | 1 | 1.1 | 5.7 |
| TOTAL | 11 | 9.5 | 9.5 | 9.9 | 10.5 | 11.2 | 12.1 | 13.2 | 6.7 |
Target Audience
- Biopharmaceutical Manufacturers : Italian and international pharma companies need Italy-specific market data to assess manufacturing expansion opportunities, capacity planning, and competitive positioning within the country's growing mRNA sector.
- Healthcare Investors & PE Firms : Investment professionals require detailed Italy market analysis to evaluate funding opportunities, portfolio company growth potential, and strategic acquisitions within the Italian mRNA synthesis and manufacturing landscape.
- Government & Policy Makers : Italian healthcare and innovation officials need market intelligence to inform policy development, funding allocation, and strategic initiatives supporting the country's biopharmaceutical sector competitiveness.
- Contract Manufacturing Organizations (CMOs) : CMOs and service providers need Italy-focused market insights to identify client acquisition opportunities, service expansion strategies, and capacity investment decisions within the regional mRNA manufacturing market.
- Research Institutions & Academics : Italian universities and research centers require market data to guide technology commercialization strategies, collaboration opportunities, and funding applications for mRNA-related research and development initiatives.
Reasons to Buy this Report
- Italy-Specific Market Sizing : Access precise valuation data for Italy's mRNA market with verified 2024 baseline ($13.59M) and 2029 forecasts ($16.63M), enabling accurate financial planning and investment decisions tailored to the Italian market context.
- Competitive Landscape Intelligence : Understand Italy's unique market dynamics, local biopharmaceutical players, manufacturing capabilities, and competitive positioning within Southern Europe to identify partnership and expansion opportunities.
- Investment & Expansion Strategy : Leverage Italy-focused insights to evaluate market entry strategies, facility location decisions, and capital allocation priorities for companies seeking to establish or expand mRNA manufacturing operations in the region.
- Regulatory & Infrastructure Insights : Gain detailed understanding of Italy's regulatory environment, healthcare sector policies, and biopharmaceutical infrastructure development initiatives that directly impact mRNA synthesis and manufacturing operations.
- Growth Opportunity Identification : Identify emerging segments, therapeutic applications, and customer segments within Italy's mRNA market to prioritize product development, marketing efforts, and commercial strategies for maximum ROI.
Frequently asked questions
What is the current market size of mRNA synthesis and manufacturing in Italy?
Italy's mRNA synthesis and manufacturing market was valued at $13.59 million in 2024 and is expected to reach $16.63 million by 2029.
What is the projected growth rate for Italy's mRNA market?
Italy's mRNA synthesis and manufacturing market is projected to grow at a CAGR of 4.1% from 2024 to 2029.
What factors are driving growth in Italy's mRNA manufacturing sector?
Italy's market growth is driven by increased biopharmaceutical investment, expanding vaccine manufacturing capacity, and supportive regulatory frameworks for gene therapy development.
How does Italy's mRNA market compare to the global market?
Italy's 4.1% CAGR is lower than the global 5.8% CAGR, indicating that Italy's market is growing at a more moderate pace than the worldwide mRNA synthesis and manufacturing sector.
What is the forecast market size for Italy's mRNA synthesis market in 2029?
Italy's mRNA synthesis and manufacturing market is forecasted to reach $16.63 million by 2029, up from $13.59 million in 2024.
RESEARCH METHODOLOGY
The study involved major activities in estimating the current market size for the mRNA synthesis and manufacturing market. Exhaustive secondary research was done to collect information on the mRNA synthesis and manufacturing industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as market share analysis, MnM repository analysis, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the mRNA synthesis and manufacturing market.
Secondary Research
The market for the companies offering mRNA synthesis and manufacturing solutions is arrived at by secondary data available through paid and unpaid sources, analyzing the product & service portfolios of the major companies in the ecosystem, and rating the companies by their performance and quality. Various sources were referred to in the secondary research process to identify and collect information for this study. The secondary sources include annual reports, press releases, investor presentations of companies, white papers, journals, certified publications, and articles from recognized authors, directories, and databases. In the secondary research process, various secondary sources were referred to for identifying and collecting information related to the study. Secondary sources included annual reports, press releases, and investor presentations of blockchain vendors, forums, certified publications, and whitepapers. The secondary research was used to obtain critical information on the industry’s value chain, the total pool of key players, market classification, and segmentation from the market and product-oriented perspectives.
Primary Research
Extensive primary research was conducted after acquiring basic knowledge about the global mRNA synthesis and manufacturing market scenario. Several primary interviews were conducted with market experts from both the demand side (such as personnel from the pharmaceutical & biopharmaceutical industry) and the supply side (such as C-level and D-level executives, product managers, marketing and sales managers of key manufacturers, distributors, as well as channels) across five major regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. Approximately 80% and 20% of primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, and online, personal, and telephonic interviews.
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Top-down approache was used to estimate and validate the total size of the mRNA synthesis and manufacturing market. These methods include market share analysis, MnM repository analysis were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry and market have been identified through extensive secondary research.
- The revenues generated from the mRNA synthesis and manufacturing market business of leading players have been determined through primary and secondary research.
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments.
Data Triangulation
After arriving at the market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable.
Market Definition
mRNA synthesis and manufacturing refers to the process of producing messenger RNA (mRNA) through in vitro transcription, followed by various purification, and characterization steps to create high-quality mRNA products suitable for research, therapeutic, or vaccine applications. The mRNA synthesis and manufacturing market encompasses the development, production, and commercialization of messenger RNA (mRNA) products, including their synthesis via in vitro transcription, large-scale manufacturing, and formulation. This market serves various applications such as vaccines, therapeutic treatments, and potentially other areas like protein replacement. It involves specialized technologies and equipment, adherence to regulatory standards, and a global supply chain network.
The study provides an in-depth analysis of the mRNA synthesis and manufacturing market based on contemporary market trends and developments, and its potential growth from 2024 to 2029. It includes detailed market trends, the competitive landscape, market size, forecasts, and the analysis of the key mRNA synthesis and manufacturing product and service providers.
Stakeholders
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
- Contract Development and Manufacturing Organizations (CDMOs)
- Raw Material Suppliers
- Market Research and Consulting Firms
- Regulatory Agencies
- Venture Capitalists
- Government Organizations
- Industry Associations and Professional Societies
Report Objectives
- To define, describe, and forecast the mRNA synthesis and manufacturing market based on product, service, application, and region
- To define, describe, and forecast the mRNA synthesis and manufacturing market based on product by end user and service by end user
- To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the mRNA synthesis and manufacturing market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to six main regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
- To profile the key players in the global mRNA synthesis and manufacturing market and comprehensively analyze their products and services portfolios, market positions, and core competencies.
- To track and analyze competitive developments such as product/service launches, expansions, agreements, and collaborations in the mRNA synthesis and manufacturing market
- To benchmark players within the mRNA synthesis and manufacturing market using the Company Evaluation Matrix framework, which analyzes market players based on various parameters within the broad categories of business and service strategy
Get the Full mRNA Synthesis & Manufacturing Market Report
Full forecast, segment splits, and company analysis for all mRNA Synthesis & Manufacturing Market.
- Canada mRNA Synthesis & Manufacturing Market
- US mRNA Synthesis & Manufacturing Market
- Germany mRNA Synthesis & Manufacturing Market
- UK mRNA Synthesis & Manufacturing Market
- France mRNA Synthesis & Manufacturing Market
- Switzerland mRNA Synthesis & Manufacturing Market
- Spain mRNA Synthesis & Manufacturing Market
- China mRNA Synthesis & Manufacturing Market
- Japan mRNA Synthesis & Manufacturing Market
- India mRNA Synthesis & Manufacturing Market
- South Korea mRNA Synthesis & Manufacturing Market
- Brazil mRNA Synthesis & Manufacturing Market
- Rest Of Europe mRNA Synthesis & Manufacturing Market
- Rest Of Asia Pacific mRNA Synthesis & Manufacturing Market
- Rest Of Latin America mRNA Synthesis & Manufacturing Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
